ENSG
Get informed when a big investor buys or sells
+ FollowUndervalued by 22.1% based on the discounted cash flow analysis.
| Market cap | $9.80 Billion |
|---|---|
| Enterprise Value | $11.37 Billion |
| Dividend Yield | $0.26 (0.15%) |
| Earnings per Share | $6 |
| Beta | 0.73 |
| Outstanding Shares | 57,771,000 |
| P/E Ratio | 26.65 |
|---|---|
| PEG | 110.35 |
| Price to Sales | 1.83 |
| Price to Book Ratio | 4.07 |
| Enterprise Value to Revenue | 2.16 |
| Enterprise Value to EBIT | 23.81 |
| Enterprise Value to Net Income | 31 |
| Total Debt to Enterprise | 0.19 |
| Debt to Equity | 0.89 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.8314▲ 9.20% |
|---|---|
| Total Calls | 285,500▼ 8.73% |
| Total Puts | 237,370▲ 2.62% |
Holdings and activity of institutional investors.
| Ownership % | 92.48%▼ 1.74% |
|---|---|
| Total Invested | $10.67B▲ 13.47% |
| Investors Holding | 573▲ 6.00% |
No data
The Ensign Group independent operating subsidiaries provide a broad spectrum of skilled nursing and assisted living services, physical, occupational and speech therapies and other rehabilitative and healthcare services at 231 healthcare ...
This committee controls Medicare and Medicaid policy; its decisions on reimbursement rates are the single most important factor for Ensign’s profitability.
Determines the precise funding levels for the Department of Health and Human Services, impacting the cash flow for federal healthcare programs.
Regulates the healthcare workforce, labor unions, and provides oversight to the Department of Health and Human Services (HHS).
Directly investigates the quality of care and business practices in nursing homes, creating significant legislative and headline risk for Ensign.
The VA is a major payer for long-term care; funding decisions and policy shifts here directly affect the revenue and occupancy of skilled nursing facilities.